|
1
|
Maruani DM, Spiegel TN, Harris EN,
Shachter AS, Unger HA, Herrero-González S and Holz MK: Estrogenic
regulation of S6K1 expression creates a positive regulatory loop in
control of breast cancer cell proliferation. Oncogene.
31:5073–5080. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Malouf GG, Taube JH, Lu Y, Roysarkar T,
Panjarian S, Estecio MR, Jelinek J, Yamazaki J, Raynal NJ, Long H,
et al: Architecture of epigenetic reprogramming following
Twist1-mediated epithelial-mesenchymal transition. Genome Biol.
14:R1442013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gomes LR, Terra LF, Sogayar MC and
Labriola L: Epithelial-mesenchymal transition: Implications in
cancer progression and metastasis. Curr Pharm Biotechnol.
12:1881–1890. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu TH, Yao Y, Yu S, Han LL, Wang WJ, Guo
H, Tian T, Ruan ZP, Kang XM, Wang J, et al: SDF-1/CXCR4 promotes
epithelial-mesenchymal transition and progression of colorectal
cancer by activation of the Wnt/β-catenin signaling pathway. Cancer
Lett. 354:417–426. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saxena M, Stephens MA, Pathak H and
Rangarajan A: Transcription factors that mediate
epithelial-mesenchymal transition lead to multidrug resistance by
upregulating ABC transporters. Cell Death Dis. 2:e1792011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Haga CL and Phinney DG: MicroRNAs in the
imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal
transition by targeting the TWIST1 protein signaling network. J
Biol Chem. 287:42695–42707. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hwang HW, Wentzel EA and Mendell JT: A
hexanucleotide element directs microRNA nuclear import. Science.
315:97–100. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li XH, Qu JQ, Yi H, Zhang PF, Yi HM, Wan
XX, He QY, Ye X, Yuan L, Zhu JF, et al: Integrated analysis of
differential miRNA and mRNA expression profiles in human
radioresistant and radiosensitive nasopharyngeal carcinoma cells.
PLoS One. 9:e877672014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang C, Li C, Li J, Han J, Shang D, Zhang
Y, Zhang W, Yao Q, Han L, Xu Y, et al: Identification of
miRNA-mediated core gene module for glioma patient prediction by
integrating high-throughput miRNA, mRNA expression and pathway
structure. PLoS One. 9:e969082014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Romano F, Garancini M and Uggeri F,
Degrate L, Nespoli L, Gianotti L, Nespoli A and Uggeri F: Surgical
treatment of liver metastases of gastric cancer: State of the art.
World J Surg Oncol. 10:1572012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lim L, Balakrishnan A, Huskey N, Jones KD,
Jodari M, Ng R, Song G, Riordan J, Anderton B, Cheung ST, et al:
MicroRNA-494 within an oncogenic microRNA megacluster regulates
G1/S transition in liver tumorigenesis through
suppression of mutated in colorectal cancer. Hepatology.
59:202–215. 2014. View Article : Google Scholar :
|
|
12
|
Olaru AV, Ghiaur G, Yamanaka S, Luvsanjav
D, An F, Popescu I, Alexandrescu S, Allen S, Pawlik TM, Torbenson
M, et al: MicroRNA down-regulated in human cholangiocarcinoma
control cell cycle through multiple targets involved in the G1/S
checkpoint. Hepatology. 54:2089–2098. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liang Z, Yoon Y, Votaw J, Goodman MM,
Williams L and Shim H: Silencing of CXCR4 blocks breast cancer
metastasis. Cancer Res. 65:967–971. 2005.PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
15
|
Shen PF, Chen XQ, Liao YC, Chen N, Zhou Q,
Wei Q, Li X, Wang J and Zeng H: MicroRNA-494-3p targets CXCR4 to
suppress the proliferation, invasion, and migration of prostate
cancer. Prostate. 74:756–767. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Peng C, Zhou K, An S and Yang J: The
effect of CCL19/CCR7 on the proliferation and migration of cell in
prostate cancer. Tumour Biol. 36:329–335. 2015. View Article : Google Scholar
|
|
17
|
Smith MC, Luker KE, Garbow JR, Prior JL,
Jackson E, Piwnica-Worms D and Luker GD: CXCR4 regulates growth of
both primary and metastatic breast cancer. Cancer Res.
64:8604–8612. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wielenga VJ, Smits R, Korinek V, Smit L,
Kielman M, Fodde R, Clevers H and Pals ST: Expression of CD44 in
Apc and Tcf mutant mice implies regulation by the WNT pathway. Am J
Pathol. 154:515–523. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: Components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nusse R, Fuerer C, Ching W, Harnish K,
Logan C, Zeng A, ten Berge D and Kalani Y: Wnt signaling and stem
cell control. Cold Spring Harb Symp Quant Biol. 73:59–66. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Benhaj K, Akcali KC and Ozturk M:
Redundant expression of canonical Wnt ligands in human breast
cancer cell lines. Oncol Rep. 15:701–707. 2006.PubMed/NCBI
|
|
23
|
Schlange T, Matsuda Y, Lienhard S, Huber A
and Hynes NE: Autocrine WNT signaling contributes to breast cancer
cell proliferation via the canonical WNT pathway and EGFR
trans-activation. Breast Cancer Res. 9:R632007. View Article : Google Scholar
|
